We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.




Our Research

Our Education Programs

The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:

  • Hiroshi Nakato, PhD

    Associate Professor

  • Christina E. Clarkson, DVM, PhD

    Assistant Professor

  • Meri Firpo, PhD

    Assistant Professor

  • In the News

    Human mesenchymal stem cell
    March 1, 2017

    When scientists can determine what type of cell a stem cell will become, they can better manipulate cells for stem cell therapy.  Scientists at Rutgers and other universities have created a new way to identify the state and fate of stem cells earlier than previously possible.  The approach, called EDICTS (Epi-mark Descriptor Imaging of Cell Transitional States), involves labeling epigenetic modifications and then imaging the cells with super resolution to see the precise location of the marks.

    March 1, 2017

    The regenerative biology team at the Morgridge Institute for Research, led by stem cell pioneer and University of Wisconsin-Madison Professor James Thomson, is studying whether stem cell differentiation rates can be accelerated in the lab and made available to patients faster.  While the study published in the February issue ofScience Direct suggests that cellular timing is a stubborn process, the Thomson lab is exploring a variety of follow-up studies on potential factors that could help cells alter their pace, Barry says.  

    Daniel Harki
    February 23, 2017

    The research team of Dr. Scott Kaufmann, leader of Mayo’s Anticancer Drug Action Laboratory, and Daniel Harki, a U of M assistant professor of medicinal chemistry, Stem Cell Institute member, and director of the Harki Lab, in January saw their patent application for a method of “assessing enzyme-nucleic acid complexes” published by the U.S. Patent and Trademark Office, with Mayo and the U of M named as the assignees.

    February 23, 2017

    Dr. Mehmet Oz investigates and uncovers the dangers of unregulated stem cell clinics, citing absence of scientific support for treatment.  Dr. Oz features a series of segments on his daytime television program that expose the scams that take advantage of the most vulnerable.

    Weekly Research Conference

    Meets weekly in Room 1-110
    McGuire Translational Research Facility (MTRF, next to Lion's Research Building)
    [map] [shuttle schedule]

    Wednesday, March 1, 2017 - 4:00pm

    Translational control of skeletal muscle stem cells

    Colin Crist

    Colin Crist, PhD
    Assistant Professor
    Department of Human Genetics
    McGill University
    Montreal, Quebec, Canada

    Wednesday, March 8, 2017 - 4:00pm

    Cell-based therapies for Parkinson's Disease

    Marina Emborg

    Marina Emborg, Md/PhD
    Associate Professor, Medical Physics
    Stem Cell and Regenerative Medicine
    Wisconsin Institutes for Medical Research
    Madison, WI

    Wednesday, March 15, 2017 - 4:00pm

    Spring Break - No Research Conference

    Research Conferences will resume on Wednesday, March 22, 2017